Tate & Lyle PLC
28 January 2008
Tate & Lyle PLC ('the Company') announces that on 28 January 2008 it purchased
through ABN AMRO Hoare Govett 315,000 ordinary shares at an average price of
479.2 pence per share.
These shares will be cancelled.
Following the purchase and cancellation of these shares the Company has
460,989,015 shares in issue (excluding 3,037,318 shares held in Treasury).
This number (460,989,015) represents the total voting rights in the Company and
may be used by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in, Tate & Lyle PLC under the FSA's Disclosure and
Transparency Rules.
Enquiries:
Tate & Lyle plc 020 7977 6189
Tim Lodge
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.